… SARS, and there is evidence of NLRP3 involvement in HIV-1 … derived from SARS-CoV-2,
SARS-CoV-1, and HIV-1 trigger a … GU-rich RNA from the SARS-CoV-2 spike protein triggering …

… This has left a greater proportion of the HIV … with SARS-CoV-2, data on HIV/SARS-CoV-2
co-infection is still scarce. Herein we summarize the global instances of SARS-CoV-2/HIV …

… use the term HIV-1 in a restricted sense to refer to the M-group only. HIV-1 is transmitted
sexually or through other body fluids such as blood and breast milk. The ancestor to the HIV-1 M …

… response that are shared with HIV-1 and could account for the … storm associated with
the acute SARS-CoV-2 infection and … of immune responses caused by HIV-1 and SARS-CoV-2. …

… of the sequence in SARS-CoV S2 protein that is analogous to the C-HR of HIV-1 gp41. This
led us to … strategy that is being applied against the HIV-1 can be adopted to fight SARS-CoV. …

… effect on HIV-1 RNA … SARS-CoV-2 vaccine over 6 months in PLWH after two doses of
vaccine. Secondary objectives were to measure the impact of the SARS-CoV-2 vaccine on HIV-1 …

… Here, we used flow cytometry to assess the magnitude, function, and phenotype of SARS
coronavirus 2–specific (SARS-CoV-2–specific) CD4 + T cells in 95 hospitalized COVID-19 …

… SARS-CoV-2 in the brain. Taking into consideration possible interactions between SARS-CoV-2
and HIV-1, … , ie, the main SARS-CoV-2 receptors, in these cells after HIV-1 infection. The …

… two human pathogens, the retrovirus human immunodeficiency virus type 1 (HIV-1) and the
… the retrovirus human immunodeficiency virus type 1 (HIV-1) and the coronavirus responsible …

… its binding to SARS-CoV-2 Mpro and draw a comparison to inhibitors of HIV protease that …
may be of important relevance to the long-term use of novel inhibitors against SARS-CoV-2. …